Transo Revenue and Competitors
Estimated Revenue & Valuation
- Transo's estimated annual revenue is currently $2.8M per year.
- Transo's estimated revenue per employee is $106,750
Employee Data
- Transo has 26 Employees.
- Transo grew their employee count by -21% last year.
Transo's People
| Name | Title | Email/Phone |
|---|
Transo Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $223.1M | 1023 | -2% | $7M | N/A |
#2 | $85.1M | 0 | N/A | $125.3M | N/A |
#3 | $75.1M | 394 | 1% | $3M | N/A |
#4 | $17.4M | 114 | 21% | N/A | N/A |
#5 | $8.5M | 62 | -2% | N/A | N/A |
#6 | $239.5M | 1122 | 12% | N/A | N/A |
#7 | $244.2M | 1144 | 4% | N/A | N/A |
#8 | $8.1M | 59 | 2% | N/A | N/A |
#9 | $44.6M | 266 | 6% | $8M | N/A |
#10 | $24.3M | 145 | 4% | N/A | N/A |
What Is Transo?
A collaborative, optimisation and automation technology platform for supply chain stakeholders to efficiently move shipments, while tracking and monitoring in near real-time. Critical and connected solutions offered holistically as a unified platform. Built-to-Adapt, Accelerated 'GO-LIVE' mode, Data Privacy, Ownership & Greater Visibility with End-End Digital Empowerment. Offered with TRANSO SHIELD to help you secure and build resilient operations.
keywords:N/A
N/A
Total Funding
26
Number of Employees
$2.8M
Revenue (est)
-21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Transo News
Wavelength Pharmaceuticals; Orchid Chemicals & Pharmaceuticals; Otto Brandes Gmbh; Shakti Bioscience; Aspen Biopharma Labs; Hana Pharm; AMGen; Transo-Pharm...
"Eu sentia tanta vergonha. Vergonha da ideia das pessoas saberem que eu transo, ou com quem eu transo". Trending Histórias.
Ela é só mais uma das minhas qualidades e hoje, talvez, eu seja uma mulher de fato, gostosa, porque hoje eu transo de fato com prazer.
Other Companies in Bangalore
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 26 | N/A | N/A |
#2 | $1.3M | 26 | N/A | N/A |
#3 | $1.3M | 26 | N/A | N/A |
#4 | $1.3M | 26 | N/A | N/A |
#5 | $1.3M | 26 | N/A | N/A |